Experts Amanda Kuit and Tim Noakes criticize the off-label use of Ozempic for weight loss, arguing it promotes a quick-fix mentality.

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel full. When the drug interacts with a receptor in the stomach, patients feel full sooner and for a longer period of time after eating. The drug does not cause weight loss directly – instead, it makes you want to eat less.

Patients on semaglutide, the active ingredient in Ozempic and the weight-loss drug Wegovy, were less than half as likely to overdose.

Television presenter James Corden claimed the controversial drug - traditionally used to treat type II diabetes - 'didn't really work'

Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on Tuesday.

Television presenter James Corden has this week admitted to having used Ozempic as a means of losing weight, but insisted that the controversial appetite-suppressing drug 'didn't work' for him.

Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is scheduled to testify on Capitol Hill Tuesday.

The term "Ozempic face" is not a medical term, but some use it to describe this type of appearance after weight loss. Here what's fact and fiction.

Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may get riskier online versions.